Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
531 News Items found
In the Clinic
Pictured: Isabelle Rivière and Michel Sadelain
Launch of Stem Cell Therapy Trial Offers Hope for Patients with Inherited Blood Disorder

Memorial Sloan Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.
In the Lab
Pictured: Joan Massagué
Study Links Cancer’s Ability to Spread with Chemotherapy Resistance

A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
In the Lab
Pictured: Douglas Levine and Petar Jelinic
New Web Tool Helps Researchers Explore How the Genome Changes in Cancer

Memorial Sloan Kettering investigators hope their new web tool will improve the accessibility of large-scale genome-sequencing information for cancer researchers everywhere, and accelerate research and therapeutic discovery.
Feature
Pictured: Bayard Clarkson
Bayard Clarkson Receives 2012 Distinguished Service Award from the American Association for Cancer Research

Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR.
Feature
Pictured: David Scheinberg
David Scheinberg Receives 2012 Emil J. Freireich Award

The MD Anderson Cancer Center presented its annual award to Dr. Scheinberg in recognition of his pioneering work in developing chemotherapeutic agents for leukemia and other cancers.
Feature
Pictured: Kathryn Anderson
Kathryn Anderson Awarded 2012 Thomas Hunt Morgan Medal

The Genetics Society of America medal honored Dr. Anderson, Chair of the Developmental Biology Program, for her lifetime contributions to the science of genetics.
Feature
Pictured: Neural stem cells
Starr Foundation Renews Gifts for Cancer Consortium and Stem Cell Research Initiative

Research at Memorial Sloan Kettering will benefit from renewed support for The Starr Cancer Consortium and the Tri-Institutional Stem Cell Initiative totaling $105 million.
Honors
Pictured: Nikola Pavletich and Alexander Rudensky
Two Memorial Sloan Kettering Investigators Named to National Academy of Sciences

Structural Biology Program Chair Nikola P. Pavletich and immunologist Alexander Y. Rudensky have received one of the highest honors given to scientists working in the United States.
Media Advisory
Antibody Therapy Prevents Gastrointestinal Damage following Radiation Exposure in Mice

A new study offers the first evidence of a drug capable of preventing lethal damage to the gastrointestinal (GI) tract caused by exposure to high levels of ionizing radiation, such as those occurring during a nuclear incident.
Announcement
Pictured: American Association of Cancer Research Annual Meeting 2012
Memorial Sloan Kettering Discoveries in Personalized Medicine Highlighted at Major Cancer Research Meeting; Investigators Honored

The American Association for Cancer Research (AACR), the world's oldest and largest professional organization dedicated to advancing cancer research, held its 2012 annual meeting in Chicago.